Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Cheol Kyu Park

Associate Professor

Chonnam National University Hwasun Hospital

South Korea

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacotherapy

50%

Pharmacology

30%

Lung Cancer

40%

Tyrosine Kinase

40%

Oncology

40%

Neoadjuvant Therapy

30%

Cancer Therapy

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles11

Nicotinamide in Combination with EGFR-TKIs for the Treatment of Stage IV Lung Adenocarcinoma with EGFR Mutations: A Randomized Double-Blind (Phase IIb) Trial

Article Link

Year:

2024

Association between Weight Change and Incidence of Dyslipidemia in Young Adults: A Retrospective Cohort Study of Korean Male Soldiers

Article Link

Year:

2024

Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial

Article Link

Year:

2023

Healthcare utilization of lung cancer patients associated with exposure to fine particulate matter: A Korean cohort study

Article Link

Year:

2023

A Propensity-Matched Retrospective Comparative Study with Historical Control to Determine the Real-World Effectiveness of Durvalumab after Concurrent Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer

Article Link

Year:

2023

Serum KL-6 levels predict the occurrence and severity of treatment-related interstitial lung disease in lung cancer.

Article Link

Year:

2023

Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR.

Article Link

Year:

2023

Phase II open‐label multicenter study to assess the antitumor activity of afatinib in lung cancer patients with activating epidermal growth factor receptor mutation from circulating tumor DNA: Liquid‐Lung‐A

Article Link

Year:

2021

Efficacy and dose of afatinib in patients with non‐small cell lung cancer after failure of prior gefitinib or erlotinib treatment

Article Link

Year:

2021

Baseline Serum Interleukin-6 Levels Predict the Response of Patients with Advanced Non-small Cell Lung Cancer to PD-1/PD-L1 Inhibitors

Article Link

Year:

2020

Glutathione Peroxidase 3 as a Biomarker of Recurrence after Lung Cancer Surgery

Article Link

Year:

2020

Collaborators11

Jinhyun Kim

Seoul National University Hospital

SOUTH KOREA

In-Jae Oh

Chonnam National University Hwasun Hospital

SOUTH KOREA

Chaeuk Chung

SOUTH KOREA

Won-Ju Park

Associate professor

Chonnam National University Medical School and Chonnam National University Hwasun Hospital

SOUTH KOREA

Jae Cheol Lee

Professor

Asan Medical Center

SOUTH KOREA

SUNG YONG LEE

Seoul National University Hospital

SOUTH KOREA

Sei‐Hoon Yang

SOUTH KOREA

Chang‐Min Choi

SOUTH KOREA

Changsoo Kim

Yonsei University College of Medicine

SOUTH KOREA

Jeong Eun Lee

Seoul National University Hospital

SOUTH KOREA

Young-Chul Kim

Professor

Chonnam National University Medical School

SOUTH KOREA

How do I reach out?

Meet Kite AI